Research Topic: antimicrobial resistance

First human case of Eidernor doerrieniae colonization in a peritoneal dialysis catheter: A warning from silent contamination

mycolabadmin

A 52-year-old man on peritoneal dialysis noticed brownish particles in his dialysis catheter. Doctors identified the particles as a rare fungus called Eidernor doerrieniae, which had never been found in humans before. Although the patient had no symptoms, doctors immediately removed the catheter and treated him with antifungal medications, which successfully cured the infection. This case shows why patients and doctors should take visible particles in dialysis catheters seriously, even when there are no obvious signs of infection.

Read More »

Study of the antagonistic relationship between gene expression biofilm of Aspergillus niger and Staphylococcus aureus that cause otomycosis

mycolabadmin

Researchers studied how bacteria (S. aureus) and fungi (A. niger) interact when both infect the ear canal, a condition called otomycosis. They found that bacteria significantly suppress the fungus’s ability to form protective biofilms by reducing the expression of genes needed for fungal growth. This antagonistic relationship suggests that mixed infections might actually be easier to treat than pure fungal infections, offering new insights for managing ear infections.

Read More »

Antifungal susceptibility testing of Microsporum canis isolated from the skin of dermatologically healthy cats

mycolabadmin

Researchers tested healthy cats in Chile and found that about 5% carried a fungus called Microsporum canis that can cause ringworm. This fungus was resistant to a common antifungal drug called fluconazole. Indoor cats were more likely to carry the fungus than outdoor cats. Because cats can spread this fungus to people, identifying carrier cats is important for preventing human infections.

Read More »

Eco-friendly biosynthesis of silver nanoparticles using marine-derived Fusarium equiseti: optimization, characterization, and evaluation of antimicrobial, antioxidant, and cytotoxic activities

mycolabadmin

Scientists used a marine fungus called Fusarium equiseti to create tiny silver particles called nanoparticles in an environmentally-friendly way. These particles showed strong abilities to kill harmful bacteria and fungi, protect cells from damage caused by free radicals, and fight breast cancer cells in laboratory tests. This green synthesis method offers a safer, non-toxic alternative to traditional chemical manufacturing while producing stable, multi-functional nanoparticles.

Read More »

Antifungal stewardship in the UK: where are we now?

mycolabadmin

This paper examines how well the UK is currently managing antifungal stewardship—the appropriate use of antifungal medications to treat serious fungal infections while preventing resistance. Experts found that since 2017, progress has been limited due to lack of funding and staff expertise, difficulties accessing timely fungal diagnostic tests, and disruptions from the COVID-19 pandemic. The panel recommends creating regional mycology networks and diagnostic centres, establishing national standards for antifungal practices, and improving education about fungal infections to better prepare the UK for rising fungal disease threats.

Read More »

Clinical insights into mixed Candida and bacterial bloodstream infections: a retrospective cohort study

mycolabadmin

This study found that when both Candida fungus and bacteria are present together in a patient’s bloodstream, the outcome is much more serious than when only Candida is present. Among patients with these mixed infections, over 60% died within 30 days compared to about 52% for those with only Candida. The research shows that giving the right antibiotics early and following proper treatment guidelines can significantly improve survival chances in these severe, life-threatening infections.

Read More »

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy

mycolabadmin

Fungal infections are a serious public health problem, but unlike cancer and AIDS, they lack strong patient advocacy movements to raise awareness and secure funding. This paper argues that patients with fungal diseases have important insights about their care needs that could help improve policies and research if their voices were heard. The authors propose establishing unified advocacy organizations, like the MyCARE Foundation, to bring patients, doctors, and policymakers together to better address this neglected health challenge.

Read More »
Scroll to Top